Driving Biosimilar Use Through Formulary Management A ‘Viable Strategy,’ CVS Execs Say
This article was originally published in The Pink Sheet Daily
Executive Summary
Formulary exclusions, step therapy and other tactics that have been used to drive use of generics may also be applied to promote use of biosimilars and maximize savings.